Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Alginate
2. Alginate, Barium
3. Alginate, Calcium
4. Alginate, Copper
5. Alginate, Potassium
6. Alginate, Sodium
7. Alginate, Sodium Calcium
8. Alginates
9. Alginic Acid, Barium Salt
10. Alginic Acid, Calcium Salt
11. Alginic Acid, Copper Salt
12. Alginic Acid, Potassium Salt
13. Alginic Acid, Sodium Salt
14. Alloid G
15. Barium Alginate
16. Calcium Alginate
17. Calcium Alginate, Sodium
18. Calginat
19. Copper Alginate
20. Kalrostat
21. Kalrostat 2
22. Kaltostat
23. Poly(mannuronic Acid), Sodium Salt
24. Potassium Alginate
25. Sodium Alginate
26. Sodium Calcium Alginate
27. Vocoloid
28. Xantalgin
1. 9005-34-9
2. 6-(2-carboxy-4,5-dihydroxy-6-methoxyoxan-3-yl)oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic Acid
3. Kaltostat
4. 3-((6-carboxy-3,4-dihydroxy-5-methoxytetrahydro-2h-pyran-2-yl)oxy)-4,5-dihydroxy-6-methoxytetrahydro-2h-pyran-2-carboxylic Acid
5. Schembl10118904
6. Akos015915207
7. A843434
8. 6-(2-carboxy-4,5-dihydroxy-6-methoxy-tetrahydropyran-3-yl)oxy-4,5-dihydroxy-3-methoxy-tetrahydropyran-2-carboxylic Acid
| Molecular Weight | 398.32 g/mol |
|---|---|
| Molecular Formula | C14H22O13 |
| XLogP3 | -3.7 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 6 |
| Exact Mass | 398.10604075 g/mol |
| Monoisotopic Mass | 398.10604075 g/mol |
| Topological Polar Surface Area | 202 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 541 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 10 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
1(?). 1= PRACTICALLY NONTOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) ABOVE 15 G/KG, MORE THAN 1 QUART (2.2 LB) FOR 70 KG PERSON (150 LB). /ALGINIC ACID/
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-155
ALGINATE PREPARED FROM LAMINARIA DIGITATA WAS UNABSORBED BY RATS FED AT LEVEL OF 10% OF THEIR DAILY DIET. /ALGINATE/
The Chemical Society. Foreign Compound Metabolism in Mammals Volume 3. London: The Chemical Society, 1975., p. 344
Market Place
ABOUT THIS PAGE
33
PharmaCompass offers a list of Kaltostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Kaltostat manufacturer or Kaltostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Kaltostat manufacturer or Kaltostat supplier.
A Protanal LF manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Protanal LF, including repackagers and relabelers. The FDA regulates Protanal LF manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Protanal LF API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Protanal LF supplier is an individual or a company that provides Protanal LF active pharmaceutical ingredient (API) or Protanal LF finished formulations upon request. The Protanal LF suppliers may include Protanal LF API manufacturers, exporters, distributors and traders.
Protanal LF Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Protanal LF GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Protanal LF GMP manufacturer or Protanal LF GMP API supplier for your needs.
A Protanal LF CoA (Certificate of Analysis) is a formal document that attests to Protanal LF's compliance with Protanal LF specifications and serves as a tool for batch-level quality control.
Protanal LF CoA mostly includes findings from lab analyses of a specific batch. For each Protanal LF CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Protanal LF may be tested according to a variety of international standards, such as European Pharmacopoeia (Protanal LF EP), Protanal LF JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Protanal LF USP).
